Identification of targeting peptides for the diagnosis of myocarditis

Current diagnostic tests for myocarditis are invasive and have low diagnostic value. Our aim was to identify potential targeting peptides to detect early myocarditis following intravenous delivery. We used an animal model of experimental autoimmune myocarditis and a phage display library to identify...

Full description

Saved in:
Bibliographic Details
Published inNanomedicine (London, England) Vol. 13; no. 7; pp. 787 - 801
Main Authors Martinez, Mario D, Trac, David Q, Brown, Milton E, Maher, Kevin O, Davis, Michael E
Format Journal Article
LanguageEnglish
Published England Future Medicine Ltd 01.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Current diagnostic tests for myocarditis are invasive and have low diagnostic value. Our aim was to identify potential targeting peptides to detect early myocarditis following intravenous delivery. We used an animal model of experimental autoimmune myocarditis and a phage display library to identify potential targeting peptides. After several steps, we selected two peptides, MyH-PhD-05 and MyH-PhD-120, for screening using fluorescent imaging. Immunofluorescence and proteonomic analysis was used to identify potential cellular and molecular targets of MyH-PhD-05. Echocardiography was used to assess functional changes. Peptide MyH-PhD-05 was able to detect animals with severe myocarditis even in the absence of functional changes. Immunofluorescence demonstrated that MyH-PhD-05 colocalizes with CD4 T cells and monocytes (CD11b ) in cardiac infiltrates. We identified potential targeting peptides for the diagnosis of myocarditis. Future studies will focus on better identification of potential targets and translating this technology to clinically relevant imaging modalities.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1743-5889
1748-6963
DOI:10.2217/nnm-2018-0023